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Human pathogenic Yersinia use a type three secretion system to deliver
various effector proteins into host cells. Once these effector proteins are within the

cell, they elicit a cascade of events that disrupt the normal immune response. One of
these effectors, YopT, is known to disrupt actin distribution but it is currently
unknown what YopT targets within the host cell. To investigate the cellular targets of

the YopT effector, we use a yeast model system and a dosage-dependent suppression
screen.

The dosage-dependent suppression screen isolated three plasmids able to

suppress YopT induced lethality within yeast. One of them, 2T9, was chosen for
further analysis. Through the creation of several subclones, we determined that the
genomic region within 2T9 was not necessary for suppression. From data collected

through Western blotting and immunofluorescence, it was concluded that YopT levels

were significantly reduced when the suppressor plasmids were present. Though we
were unable to determine how or why suppression was occurring in the 2T9 plasmid,
this research has provided proof that the genomic insert within 2T9 in not a YopT
cellular target.
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Chapter I: Introduction
Yersinia Infections Today

Since the first recorded cases of Y. pestis during the6th Century, this microbe
has been responsible for an estimated 200 million deaths worldwide (Perry et al.

1997). Y. pestis is the causative agent of the bacterial infection commonly known as
the plague, or Black Death. It has gained most of its recognition from historical

events throughout the Dark Ages. During the 13th through 19th centuries, this disease
killed approximately one third of the population in Europe (Perry et al. 1997).
Though the majority of epidemics and pandemics occurred prior to the 19 century,
this disease still remains a world heath concern. Rural regions of Asia and Africa are

experiencing a re-emergence of this infection (Stenseth et al. 2008). In 1994, western
India experienced a Y. pestis outbreak that lasted two months and created widespread

hysteria (Perry et al. 1997). More recently, in 2006 the Southwestern United States
reported thirteen cases resulting in two deaths (Butler 2009).

The re-emergence of plague can be attributed to several factors. The first

factor influencing the recent spread of plague is the poor living conditions found in
rural areas of Africa. Most of the housing facilities in these areas are in close

proximityto rodents. These rodents, which harbor the microbe, are often used as a
food source. Commonly, these rural areas also lack adequate health care and the

infected patient is unable to receive medical treatment in time. Second, countries
undergoing political turmoil and social disorganization often have insufficient
healthcare systems which can limit the amount of aid given to regions undergoing an
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epidemic. The lack of protocols put in place to prevent the spread of infection leads to
an increase in not only the number of cases, but the area to which the disease spreads
as well. Another factor contributing to the re-emergence of plague is the change in
geography. As we reshape the normal landscape, we allow for greater exposure to
rodent reservoirs. Also, an increase in global travel allows for the spread of infection
to new regions that have not previously been affected (Stenseth et al. 2008).
In the future, the risk associated with possible outbreaks increases. One
reason for this is climate change. Warmer springs and wetter summers have been

shown to increase the prevalence of Yersinia in its animal hosts (Stenseth et al. 2006).
This type of climate change has been predicted for North America and Central Asia
(Stenseth et al. 2008). Another factor contributing to the rising risk of plague
outbreaks is the possibility of antimicrobial resistance. Currently, there is no vaccine

for human pathogenic Yersinia and the main treatment consists of antibiotics. This
creates the possibility of multidrug resistant Yersinia strains. An example of this
occurred in Madagascar in 1995. The Yersinia strain isolated from this outbreak was
shown to contain a self-transmissible plasmid that was resistant to eight different

antibiotics. Another possibility is the acquiring of new ethological agents through
homologous recombination with other pathogens (Welch et al. 2007).
Yersinia outbreaks elicit fear and panic among the public. Though the death
toll from this infection has decreased in recent decades, the fear associated with it still

remains. Most of this is due to the possibility of weaponizing the microbe. For
centuries cultures have been weaponizing plague by throwing infected bodies over city

walls or dispersing infected fleas into populations. Another more recent tactic has

been the creation of aerosol inhalants that spread the bacteria through respiratory
droplets (Stenseth et al. 2008). The potential for weaponization of Yersinia leads to a
greater need for research that aids in the understanding of how this microbe lives
within its human host.

Though the possibility of a worldwide epidemic as devastating as the Black

Death is unlikely, Yersinia still remains a threat to the world's population. Whether
it's the change in climate, risk of increased antimicrobial resistance, or the fear of

weaponization, Yersinia still has the potential to infect great numbers of people.
Understanding the complete mechanism of pathogenesis and how Yersinia functions

within its host is crucial to protect against future potentially devastating outbreaks.

Human Pathogenic Yersinia and the Yops
Yersiniae are gram negative coccobacilli belonging to the family
Enterobacteriaceae. They are non-motile, non-spore forming facultative anaerobes.

Of the eleven known Yersinia species, three have been identified as pathogenic to

humans: Y. pestis, Y. enterocolitica, and Y. pseudotuberculosis. The most widely
recognized of the three is Y. pestis, which causes the plague. The other two

pathogens, Y. enterocolitica and Y. pseudotuberculosis, are less commonly known.

Both species cause enteric infections, but Y. pseudotuberculosis can also manifest
symptoms that resemble tuberculosis (Cover & Aber 1989). Y. pestis is spread to
humans via an infected rodent, flea or another human. Y. enterocolitica and Y.

pseudotuberculosis are spread only from human contact (Fallman et al. 2002). All

three of the pathogenic species grow in the lymph nodes and are closely related
because they have similar mechanisms of pathogenesis in mammalian hosts (Straley et
al 1993).

Human pathogenic Yersinia species have several virulence factors that allow

them to thrive in mammalian hosts. In a typical infection, once a bacterial cell has
entered into the body, the immune response is initiated. The presence of different

bacterial cell markers triggers professional phagocytes such as macrophages and
leukocytes to ingest and degrade the foreign bacteria (Fallman et al. 2002). In order

to evade this immune response, Yersinia cells produce effector proteins, called Yops
(Yersinia outer proteins), which are secreted into the host cell via a type three

secretion system (TTSS). This secretion system consists of approximately 27 proteins
and uses a needle-like appendage, called an injectisome, to translocate effector
proteins from the bacterial cell directly into the host cell cytoplasm (Broz et al. 2007).
The formation of the injectisome and the translocation of its effectors, are triggered by

the recognition of body temperature (Cornells 2002). Once inside the cell, the Yops
will work together to disrupt various cellular functions. Several of these effectors are

directly involved in prevention of phagocytosis (Apefelbacher et al. 2007).
Along with the type three secretion machinery, there are six different Yop
effectors that are encoded on a 70kb virulence plasmid called pYV (Apefelbacher et

al. 2007). Of these six effectors, YopT, YopE, YopO and YopH all work together to

prevent the formation of lamellipodia. Lamellipodia are arm-like projections on

phagocytes that contain an actin cytoskeleton. These projections are used to surround
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foreign material in order to bring it into the cell for degradation (Owen et al. 2007).

The Yops each use different molecular mechanisms in order to cause actin
cytoskeleton breakdown and prevent formation of the lamellipodia.
YopE, YopO and YopT all target the Rho GTPase cycle, which regulates the

actin cytoskeleton. YopE is a 23 kDa GTPase activating protein that down-regulates
Rho GTP binding proteins (Apefelbacher et al. 2007). This down-regulation prevents
the assembly of filamentous actin (Soon-Tuck & Manser 2011). YopO from Y.
enterocolitica is an 82 kDa serine threonine kinase. The effector YdkA from Y. pestis

and Y. pseudotuberculosis is a closely related homologue. It uses SycO as a

chaperone, and auto-phosphorylates upon stimulation with actin (Apefelbacher et al.
2007). It interacts with Racl to inhibit the intrinsic guanine nucleotide exchange of
GDP for GTP. This causes inactivation of Racl and prevents the formation of actin

fibers. Another effector, YopT, is a cysteine protease that localizes to the cell
membrane. It untethers G-proteins RhoA, Racl and CDC42 from the membrane

through cleavage of an isoprene group (Trotsky et al. 2008). This cleavage leaves the
GTPases inactive and no longer able to control actin cytoskeleton rearrangement.

YopH is 51 kDa tyrosine phosphatase protein. It dephosphorylates focal adhesion
kinase (Fak), pavilion, and Fyn-binding protein (Fib) (Apefelbacher et al. 2007). This

dephosphorylation disrupts the interaction between the actin cytoskeleton and
extracellular matrix-binding integrins, thereby preventing the formation of focal
adhesions and disrupting phagocytosis.
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The last two effectors, YopM and YopJ, are the least understood of the Yops.

YopM is a 42 kDa protein that is thought to act as a scaffold for two kinases known
as Rskl and Prk2. This scaffolding results in downstream activation of more kinases.
It is the only Yop effector not to contain catalytic activity (Trosky et al. 2008).
Lastly, YopJ from Y. pestis and Y. pseudotuberculosis, and YopP from Y.
enterocolitica, are 31 kDa proteins that are not essential for Yersinia virulence

(Straley et al. 1993). They disrupt the innate immune response and promote apoptosis
of macrophages by targeting MAPK kinases and IkB kinase-P (Trosky et al. 2008).
Though each Yop effector protein has its own function, they are thought to
work together in order to prevent degradation of the bacterial cell after it has entered

the body. With the exception of YopM, all of the effectors are essential for survival
within its mammalian host. These effective virulence factors are what keep human

pathogenic Yersinia thriving in different populations worldwide millennia after its first
emergence. Even though there has been a recent outpouring of knowledge on the

Yops, the complete mechanism to pathogenesis remains unknown. In order to gain a
better understanding of how these Yops function, an effective and efficient model
system must be used to study them.

Yeast History
For centuries budding yeast, also known as Saccharomyces cerevisiae, has
been an important tool used in cultures around the world. Civilizations such as

Babylonia and Sumerused yeast for brewingbeer as early as 6000 B.C. (Hornsey
2003). In China, evidence of fermented beverages has been discovered as early as
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7000 B.C. (Legras et al. 2007). S.cerevisiae was first observed under a microscope
by Antony van Leeuwenhoek in 1680. Then, in the 1860's, Louis Pasteur discovered
that yeast was a living organism and was the agent responsible for alcohol

fermentation and dough leavening (Barnett 2010).

Since becoming the first eukaryotic genome to be sequenced in 1996,
researchers have utilized yeast as an important tool in scientific research (Dujon 1996).

Scientists began using S. cerevisiae as a model organism in the mid 1930's, and it has
become one of the most popular model organisms used in research today (Roman

1981). For example, yeast has played a vital role in the understanding of
mitochondrial genetics as well as vacuolar function (Borkovich and Ebbole 2012).
The large success of yeast as a model organism can be attributed to the many unique
features of yeast that make it advantageous.

Yeast as a Model System
Many properties ofS. cerevisiae make it an ideal model organism for
molecular research. First, S. cerevisiae is a simple unicellular fungus, which provides

the advantage of working with an organism that needs few nutrients to survive, but
still contains a nucleus. Also, many molecular processes such as cellular repair and

replication are conserved throughout eukaryotes (Guthrie and Fink 1991). This
homologybetween eukaryotes allows researchers to make comparisonsbetween yeast
and higher order organisms such as mammals (Feldmann 2010).
There are various advantages of S. cerevisiae that make it more favorable than

other organisms to work with in the laboratory. First, yeast is nonpathogenic to
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humans. Therefore, it can be handled with limited precautions and without special

equipment (Sherman 1991). Other model microorganisms, such as Escherichia coli,
require biosafety precautions that do not apply when working with yeast. Another
attractive feature of yeast is the ability to grow on defined media. This enables the

researcher to have complete control over environmental parameters. Also, it allows
for colony selection through the use of nutritional auxotrophs.

Another benefit of S. cerevisiae is its quick generation time. Yeast reproduces

by generating a complement daughter cell though budding. This method of

reproduction is advantageous because it allows for a fast doubling time of-90 minutes
at 30°C (Watson et. al 1987). This fast generation time permits yeast to be cultured

quickly, in mass amounts, and at a low economic cost. Also, mutants can be created
and selected quickly since many generations of progeny can be created in a short time.

Another unique feature of yeast is its life cycle. S. cerevisiae is viable in both

haploid and diploid states, depending on nutrient availability. Whenthe cell is in an
adequate nutrient environment, two haploid cells of differing mating types (a and a)
can mate to form a diploid cell. When the cell is in a nutrient deprived environment, it

undergoes meiosis to form four haploid sporesthat are encapsulated in a thickwalled
sac called an ascus (Watson et. al 1987). The ability to exist in the haploid state

allows for recovery of recessive mutations while the diploid state can be used for

complementation tests and homologous recombination. Since yeast can existin both
states, there is a large capacity to carry out multiple methods of experimentation.
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Yeast is known to contain 16 chromosomes with over 6,000 open reading

frames that are predicted to produce protein products (Sherman 1991). The genome
is 12.8 Mb, which makes it larger than E. coli (4.6 Mb), but significantly smaller than
the human genome (3.2 Gb) (Blattner et. al 1997, Guthrie and Fink 1991). Also, yeast
contain extra-chromosomal elements such as the 2u plasmid sequence which is a 6.3
kb circular DNA sequence that is found at about 50-100 copies per cell (Strathern

1981). This plasmid sequence provides the ability to easily overexpress genes within
the cell through plasmid selection.

Lastly, yeast is advantageous over other model organisms because of the large
amount of information currently available to researchers. Since the completion of the
yeast genome project, scientists have created several online yeast databases containing
a wealth of knowledge (Dujon 1996). The accessibility of information from these
online databases has led to a greater availability of perfected genetic protocols. One
example is the high efficiency yeast transformation which allows for easy addition or
deletion of genes through homologous recombination (Orr-Weaver et al. 1981). This

allows for specific location integration of plasmids containing foreign sequences
(Sherman 1991). Another example is the two-hybrid screen that is used to determine
protein-protein interactions.
All of these factors combined make yeast a very effective model organism.
The low economic cost, ability to control environmental parameters, and the ease of
working with a nonpathogenic organism all have made yeast an important tool in

biological research. In the last century, S. cerevisiae has become one of the most
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efficient model organisms in molecular cloning experiments due to its small genome

size and the availability of perfected genetic protocols. In the future, yeast will
continue to be a valued model system due to the large availability of information that is
accessible through online databases.
Conclusion

The recent re-emergence of plague has led to an immediate need for research
on how this pathogen infects and survives within its human hosts. In the last decade, a
slew of literature has been published regarding the pathogenesis of Yersinia and its

Yop effectors. However, with this new information, many new questions arise. What

do these Yop effectors target within the host cell? How do they work together? What

other genes are necessary for proper functioning? Do these effectors need buffers or
chaperones in order to reach the intended cellular targets? All of these questions are

important for understanding the establishment of Yersinia infections. To begin to gain
answers to these questions, researchers are developing new ways to study gene
interactions without the limitations of single mutant phenotypic studies. One example,

the Synthetic Genetic Array (SGA), can be used to determine genetic interactions

through the use of a systematic screen. This new experimental approach can be used

to investigate the cellular targets of the Yops using yeast as a model system, and thus
give insight into how this prevalent pathogen survives.
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Chapter II: Study Design and Results
Introduction to Systematic Genetic Screening
Synthetic Genetic Array

With the recent wealth of knowledge gained from genome sequencing projects,

scientists are beginning to investigate the functions of thousands of highly conserved

genes. Also, they are examining new ways to determine how these genes work

together within complex biochemical pathways and cellular processes. The use of
single mutant phenotypic studies as an effective way to determine gene function is
limited by the realizationthat most genes act as buffers for other genes within the same

pathway. For example, Saccharomyces cervisiae haploid cells can still survive when
5,000 of the 6,000 predicted genes are deleted (Baetz et al. 2006). Therefore, some

cellular processes may be directed by several genes that work in unison.

By the end ofthe 20th century, there was a strong need for an efficient
approach to investigate genetic interactions. The emergence of a Synthetic Genetic

Array (SGA) technique provided researchers with a systematic wayto screen for

genetic interactions. SGA canbe divided into two types of approaches, synthetic
lethal and synthetic dosage lethal arrays. In synthetic lethal arrays, a gene of interest is
mutated so that it no longer functions properly. Systematically mutating all other non

essential genes, and creation of a double mutant that has a phenotype that is distinct
from that of either single mutant, indicates the presence of a genetic interaction. For

example, when a single mutation causes cells to be less viable than wild type, and the
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addition of a second mutation that is not essential for viability in a different gene

causes lethality, the two genes may interact with other (Baetz et al 2006).
Another type of assay, synthetic dosage lethal, uses the same principle as

synthetic lethal, but instead of a loss-of-function mutation, the genes are over-

expressed. The over-expression of the genes themselves have no known effect on wild
type, but a different phenotype can be observed if a mutation lies in another gene
within the same biochemical pathway. For example, the expression of a gene of
interest causes lethality, while the over-expression of a different gene within the same

pathwaywill suppressthe lethality. Sincethe increased amount of the second gene
was able to compensate for loss from the lethalityof the first gene, then the two genes

may interact with one another. The process of systematically screening all over-

expression phenotypes is referred to as dosage-dependent suppression screening and
can be used to identify cellular targets of proteins (Baetz et al. 2006).
Dosage-Dependent Suppression Screening

The dosage-dependent suppression screen has been shownto be effective in

the model system Saccharomyces cervisiae (DeChamps et al. 2005, Burgeret al
2000). It can also have implications in other organisms as well. For example, it is
currently known that 30 percent of the genes that are identified to play a role in human

disease have yeast orthologues. This is mostly dueto the fact that the components of
DNA repair machinery and cell division are highly conserved (Foury 1997). Because
of this homology, researchers can use bioinformatical analysis to look for orthologues
in other organisms.
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The dosage-dependent suppression screen in yeast uses a multicopy plasmid
library. Each clone within the library contains a fragment, or insert, of the yeast

genome and a 2u sequence that allows for over-expression of the insertedgenes. Each

library cloneis transformed into yeast, and the over-expression phenotype is examined.
Thus, the phenotype of only a few genes at a time can be viewed, as opposed to the
entire genome. This suppression screening technique has many applications in the field
of biotechnology and its methodology has been proven to be effective.

Dosage-dependent suppression screeninghas useful implications for cancer
treatment. One exampleis a study conducted on cisplatin resistance by Burger and

colleagues in 2000. Cisplatin based chemotherapy is frequently used to fight against
cancer but, over time, cellular resistance can occur. In order to isolate resistance

genes, a plasmid library was created by cloning 5-20 kb fragments of the yeast genome
into multicopy vectors. The plasmid library was transformed into cisplatin-sensitive

mutant yeast cells and plated onto selective media containing cisplatin. Colonies that
could grow in the presence of cisplatin were considered to contain the genes

responsible for the resistance phenotype andwere selected for further analysis.
Sequencing andbioinformatical analysis revealed the presence of the PDE2 genein
resistant strains. This gene is important because it is known to induce cisplatin
resistance in mammalian cells as well (Liu et al. 1998). This provides proof that the

experimental approach used for this study was appropriate to isolate cisplatin
resistance genes using a multicopy genomic library.
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In 2005 Dechamps et al. used suppression screening to investigate vesicular

trafficking genes in yeast. The Saccharomyces cervisiae genes msb3 and msb4 have

been previously shown to act as GTPase-activating proteins by facilitating exocytosis
and actin cytoskeleton rearrangement in vesicular trafficking (Gao et al. 2003 &
Albert and Gallwitz 2000). To investigate other possible interacting genes/proteins in

the process ofmsbS and msb4, a suppression screen was conducted on cells containing
an msbS msb4 double mutation. The yeast genome was isolated into 2-5 kb fragments
and the multicopy library was then transformed into yeast harboring the double
mutation and grown on media containing DMSO or caffeine. Colonies that could

overcome growth inhibition in the presence of caffeine were considered to contain

suppressor plasmids. From this screen, six suppressor genes were identified, classified,

and the phenotypeswere obtained. This method of multicopy suppression screening
has proven to be useful in determining cellular components that are involved in poorly
understood biochemical pathways.
Conclusion

Over the last decade, advancements have been made to aid in the

understanding of complex biochemical pathways. The emergence of synthetic lethal

and synthetic dosage lethal assays has allowed researchers the ability to screen for
specific genetic interactions withinthese pathways. This technique does not
encompass the limitations that can be found in single mutant phenotypic studies and it
can be performed on essential genes. The use of a dosage-dependent suppression
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screening technique allows researchers to begin to identify the cellular targets of genes
that work together to carry out various cellular processes.
Previous Research

Expression of Effector Proteins in Yeast

Constructs containing one of three Yop effector proteins, YopO, YopE and
YopT, have been created for expression in Saccharomyces cervisiae. When

expressed, these effectors cause lethality, or cell death (Nejedlik et al. 2004 and
Nejedlik, L. unpublished data). The similarity in phenotype between the three Yops
has led researchers to propose that the three Yops have the same or similarcellular

targets. The study of YopO expression in yeast concluded that growth inhibition is
not due to the arresting of the cell during a specific phase within the cell cycle, but

rather that YopO kills the cell regardless of its place within the cell cycle.
Furthermore, YopO localizes to the cell periphery where it disrupts normal actin
distribution (Nejedlik et al. 2004). It is currently unknown whether YopE or YopT

also locate to the periphery to cause the same or a similar effect (Lesser et al. 2001).
Though three of the six Yop effector proteins are lethal in yeast, not all type
three secretion system effectors inhibit growth ofSaccharomyces cervisiae. One

example of this is found in the plant pathogen Pseudomonas syringae. Pseudomonas
syringae use a type three secretion apparatus to secrete over 30 different Hop
effectors, or Hrp Outer Proteins, across host cell membranes (Buell et al 2003, Grant

2006). The Hops deactivate the normal plant immune system and establish infection of
the bacterium. In a study published by Munkvold et al in 2008, 27 Hop effectors
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were tested for lethality in yeast. Of these 27, only five were shown to inhibit growth
while two elicited cell death. The remaining effectors neither inhibited cell growth nor
elicited cell death (Munkvold et al. 2008). In order to flirther investigate these results,

3 Hop effectors (HopAOl, HopAFI amd HopMl) were tested for lethality in yeast.
Of these three, HopAOl and HopAFI were found to inhibit growth while HopMl was

not lethal in yeast (Revindrin, V. unpublished data). Therefore, it is not simply the
expression of the effectors themselves that causes lethality in yeast.
Suppression of YopT

The Yersinia effector, YopT was chosen for the dosage-dependent suppression

screen to identify cellular targets. For this screen, a Yeast Genomic Tiling Collection

of plasmids was used. This plasmid library consists of over 1, 500 unique plasmids
that make up an overlapping collection of the yeast genome. The plasmids contain a

yeast-£. coli shuttle vector (pGP564) that is comprised of a LEU2 selectable marker

along with a 2u sequence for over-expression. The average insert size is 10Kb and
contains approximately 4-5 genes. This plasmid library was cloned into
Saccharomyces cervisiae along with an expression plasmid harboring the YopT gene
under control of the GAL I inducible promoter.

To conduct the dosage-dependent suppression screen, the growth phenotypes

of allthe library plasmids were observed. In colonies that displayed growth inhibition,
a cellular target was not likely to be contained within that plasmid. This is due to the

fact that YopT was able to interact with its cellular target normally to elicit cell death.
Conversely, in cultures where growth was not inhibited, that library plasmid is a
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suppressor plasmid and was thought to contain a possible cellular target. This is due
to the fact that while YopT interacts with its cellular target, the over-expression of the

suppressor plasmid creatse extra copies of the target within the yeast cell that can
compensate for the YopT induced lethality. Therefore, if a plasmid is able to suppress
lethality, it is thought to contain a cellular target. The phenotypes of all the library
plasmids were observed and three plasmids were found to suppress YopT lethality:
2T9, 10T14, and 10T15 (Geiser, JR. unpublished data). From these three, 2T9 was
selected for further analysis.

The plasmid 2T9 contains 3 yeast genes in its insert: SUL1, VBA2 and PCAI.
The first gene, SUL1, is a high affinity sulfate permease. It transports sulfate across

the plasma membrane so that it can be assimilated into S-amino acids. Also, it is a
member of the SulP anion transporter family (Smith et al. 1997). The next gene

VBA2, is a permease that mediates transport of amino acids into the vacuolar

membrane. This gene will transport basic amino acids such as histidine, arganine and

lysine. Also, VBA2 can be used to transport tyrosine. It is considered a member of
the basic amino acid transporter family which is a subset of the larger major facilitator

superfamily, or MFS (Shimazu et al. 2005). The last gene, PCAI, is a cadmium

transporterP-type ATPase. PCAI functions as an efflux pump to remove toxic metals
such as cadmium and copper from the cell. It is a member of the Pm-type ATPase

family of heavy metal transporters (Adel et al. 2007). Interestingly, all three of the

yeast genes isolated on the 2T9 plasmid function as membrane transporters. Though
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each gene has a separate and unique function, they all seem to act as the pore, or
pump, through which molecules are translocated.

Specific Aims
1. To identify the gene of the cellular target of YopT that resides in the

genomic insert of the 2T9 plasmid. The unique 2T9 library plasmid is able to

suppress YopT induced lethality; therefore, the genomic insert contained
within this plasmid is thought to contain a possible cellular target gene. There

are three yeast genes located within this plasmid: SULI, VBA2 and PCAI. The
region required for suppression may consist of a single gene, a fraction of a
gene, or multiple genes working together. The goal of this research is to
isolate the region within 2T9 needed for suppression. This will be

accomplished by the creation of several subclone constructs through standard
molecular cloning procedures (Sambrook et al. 1989). These subclones will
then be tested for suppression of YopT lethality by assessing growth

phenotypes through serial dilution replica plating. Once the fragment of 2T9
that is necessary for suppression has been isolated, we can begin to understand
how this suppression is occurring.

2. Identify the sub-cellular location of the YopT protein. To give insight into
the mechanism of suppression of YopT induced lethality, it is important to

localize YopT within yeast cells. Then, we can examine if the putative

suppressor has an effect on YopT localization. The goal of this research is to
determine if the location of YopT and the identified suppressor coincide.
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Cellular localization will be accomplished by immunofluorescence as previously
described (Nejedlik et al. 2004). The putative suppressor may be deactivating

YopT by derealization, or degradation of the protein. It is also possible that
the suppressor is able to repress the GAL1 promoter, thus preventing
expression of YopT. Once it has been determined where YopT is located in

the presence of the suppressor, we can begin to theorize how the suppressor is
preventing lethality.
Methods and Materials
Media

All yeast media (YPD, SD-leu, SD-ura, SD-ura-leu, Sgal-ura, Sgal-leu, Sgal-ura-leu)

were prepared as previously described (Guthrie and Fink, 1991). All LB media (LB +
ampicillin, LB + Kanamycin) were prepared as previously described (Sambrook and
Russell 2001).

Yeast Strains

Table 1: Yeast strains used in this study.
Strain

Chromosomal

JGY4

MATa lys2-801 his3-A200 Ieu2-3,I12 ura3-52

JGY3

MATa ade2-801 his3-A200 leu2-3,112 ura3-52

JGY709

MATa/MATa ade2-101/ADE2 LYS2/lys2-801 his3200/his3-200 Ieu2-3,112/leu2-3,112 ura3-52/ura3-52
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Yeast Transformation

Transformations of yeast strains were performed essentially as described
(Gietz and Schiestl, 1991).
Bacterial Transformation

Plasmid DNA was transformed into chemically or electrically competent
DH5a or XL-1 blue cells. Colonies were grown overnight on LB+ampiciliin or
LB+kanamyacin media and an alkaline lysis miniprep was performed to isolate
plasmids DNA (Sambrook and Russell, 2001).
Serial Dilution Replica Plating

Transfomants were grown overnight in S raffinose-ura-leu minimal media to a

final raffinose concentration of 2%. Cultures were serially diluted by 40-fold and
induced by plating into Sgal-ura-leu media. They were incubated for 3 days at 30°C.
Culture Preparation

Yeast strains were grown overnight with shaking at 30°C in S raffinose-uraleu minimal media (2% final concentration of raffinose). Cultures were then diluted
to 30 klett in fresh S raffinose-ura-leu media. These diluted cultures where then

grown at 30°C for ~5 hours until mid-log phase was reached (-80 Klett). Samples
were collected for immunofluorescence and western immunoblotting at time point

zero, and the cultures were then induced with galactose to 2% final concentration.
Cultures were allowed to continually grow for ~4 additional hours and samples were
collected at two, three and four hour time points.
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Immunofluorescence

Immunofluorescence was performed essentially as described (Nejedlik et al.

2004). Slides were viewed using a Leica DM5500 microscope using a Q-Imaging
Retiga Exi 1394 Fast camera and Image Pro 6.0 software.
Sample Preparation

Samples were collected in 15ml aliquots and Phenylmethanesulphonylfluoride
(PMSF) was added to a final concentration of 1 mM, to inhibit proteases. Samples
were washed with 1 ml of water, and spun in a microcentrifuge. The supernatant was

removed and the resulting pellet was resuspended in 500 ul of GFO with protease

cocktail. GFO is made up of 50 mM Tris pH 8.0, 150 mM NaCl, 2 mM MgCl2 and

0.2% Tween 20. The protease cocktail consists of 1 mM PMSF, 1 ug/ml pepstatin

and 1 ug/ml leupeptin. Approximately one half of the total volume of acid-washed
glass beads were added to each sample. The samples were then bead beaten by
vortex at 30 second intervals for 10 minutes at 4°C in order to break down the cell

wall. The samples were placed on ice for 30 seconds in between intervals. The
samples were then centrifuged for 10 minutes in a microcentrifuge at 14000 rpm at
4°C. The supernatant was removed and placed in a fresh eppendorfftube.
Western Blotting

Western immunoblotting of proteins was performed as previously described
(Nejedlik et al. 2004).
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Yop Expression Plasmids

Table 2: Yop effector expression plasmids used in this study.
Expression
Plasmid

Yeast Markers

pJG495

6H-CYClterm

pJG494

6H-CYClterm

pLN5

6H-CYClterm

Bacteria Markers

CEN6 ARSH4 URA3 PGALl-YopT-V5bla fl attRl attR2

CEN6 ARSH4 LEU2 PGALl-YopT-V5bla fl attRl attR2

CEN6 ARSH4 URA3 PGALl-YopO-V5bla fl attRl attR2

CEN6 ARSH4 URA3 PGALl-YopE-V5pJG491

6xHis-CYClterm

bla fl attRl attR2

CEN6 ARSH4 URA3 PGAL1-V5-6H-

bla fl attRl CmR

pJG485

CYClterm

ccdB attR2

CEN6 ARSH4 LEU2 PGAL1-V5-6H-

bla fl attRl CmR

pJG484

CYClterm

ccdB attR2

Creation of 2T9 Sub-clones

All digestions were performed per New England Biolabs enzyme standard
reaction protocols. All reactions were run on a 1% agarose gel.
To create pRCl and pRC8, pJG551 (2T9) was digested with Hindlll. The 9.2
kb band was isolated and reclosed through ligation. To create pRC2, pRS426 was
digested with Hindlll and Spel and the 5.7 kb band was isolated. Next, pJG551 (2T9)
was digested with Hindlll and Xbal and the 1.5 kb band was isolated. The 5.7kb and
1.5 kb bands were then ligated together. To create pRC3, first pRS426 was digested
with NotI and EcoRI and the 5.7 kb band was isolated. Then, pRCl was digested
with NotI and EcoRI and the 1.7 kb band was isolated. The 5.7 kb and 1.7 kb band

were then ligated together. For creation of pRC4, pGP564 was digested with Xhol
and SacI and the 7.1 kb band was isolated. Next, pRCl was digested with Xhol and
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Sad and the 1.7 kb band was isolated. Then, the 7.1 kb and 1.7 kb bands were ligated
together.
To create pRC5, pRCl was digested with Hindlll. After 1 hour, luL of T4

DNA polymerase and luL of nucleotides were added and allowed to sit at 37°C for 1
additional hour. From this reaction the 7.1 kb band was isolated. Next, pRC3 was

digested with EcoRI for 1 hour, then with addition of luL of T4DNA polymerase and
luL of nucleotides for 1 hour. The reaction was then heat shocked for 15 minutes at

65°C. Lastly, NotI was added and the reaction continued for 1 additional hour. From
this reaction the 1.7 kb band was isolated.

The 7.1 kb and 1.7 kb fragments were

ligated together. For creation of pRC6, pRCl was digested with Hindlll and NotI for
1 hour. Then, luL of T4DNA polymerase and luL of nucleotides were added and the
reaction continued for an additional hour. The 7.2 kb band was isolated and ligated

In order to create pRC7, pGP564 was digested with NotI and the 6.6 kb band was
isolated and ligated. Lastly, for creation of pRC9, pGP564 was digested with NotI
and the 6.6 kb band was isolated and ligated. All created plasmid constructs were

confirmed by sequencing to assure that no mutations had been incorporated during

experimentation. Table 3 summarizes the creation of all subclones.
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Table 3: Summary of creation of the 2T9 subclones.
2T9

Plasmid

subclones

Template(s)

pRCl

pJG551 (2T9)

Markers

Enzyme(s)

Size

Hindlll

9.2 kb
7.2 kb

KanRLEU2
2micron ARS228

AmpR URA3
pRC2

pRS426

2micron ARS228

Hindlll, Spel

pJG551 (2T9)

KanRLEU2
2micron ARS228

Hindlll, Xbal

AmpR URA3
pRC3

pRS426

2micron ARS228

NotI, EcoRI

7.2 kb

KanRLEU2

pRCl

2micron

NotI, EcoRI

KanRLEU2

pRC4

pGP564

2micron

Xhol, Sad

8.8 kb

KanRLEU2

pRCl

2micron

KanRLEU2

pRC5

pRCl

2micron

AmpR URA3
pRC3

2micron ARS228
KanRLEU2

pRC6

pRCl

pRC7

pGP564

pRC8

pJG551 (2T9)

pRC9

pJG551 (2T9)

2micron

Xhol, Sad
Hindlll, NotI, T4
DNA Polymerase
EcoRI, NotI, T4
DNA Polymerase
Hindll, NotI, T4
DNA Polymerase

8.8 kb

7.2 kb

KanRLEU2
2micron

NotI

6.6 kb

Hindlll

9.2 kb

NotI

6.6 kb

KanRLEU2

2micron ARS228
KanRLEU2
2micron

Results

YopE and YopO Lethality Suppression
Previous research has discovered that YopE, YopO and YopT effector

proteins cause growth inhibition when expressed in yeast (Nedjedlik 2004 and Geiser,
J.R. unpublished data). These results have led us to propose that these three Yops
have the same or similar cellular targets. To determine if the suppression of yeast
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have the same or similar cellular targets. To determine if the suppression of yeast
lethality seen by the 2T9 library plasmid was specific to YopT, lethality by the other
two Yops was examined as well. The suppressor subclone pRC6 was expressed in

yeast cells containing a YopT, YopO or YopE expression plasmid. The growth
phenotypes were then examined by serial dilution replica plating on SD-ura-leu and

Sgal-ura-leu medium. Serial dilution replica plating is a growth assay that assesses
cell viability. This assay is able to distinguish between complete growth inhibition

versus partial growth inhibition of colonies. Since the YopT gene is under control of

the GALl promoter, plating on media that contains either dextrose or galactose allows
for growth phenotypes to be examined in un-induced and induced cultures. As shown

in Figure 1, the pRC6 suppressor was able to suppress lethality in all three of the Yop
effectors. Therefore, the suppression of Yop effector induced lethality is not unique

to YopT. The consistency of suppression between the Yops by the pRC6 plasmid
suggests that suppression of YopO, YopE and YopT may occur via a similar
mechanism.

Suppression of YopT Lethality by 2T9 Sub-clones

To investigate the cellular targets of the Yops, it is important to understand what

region of the 2T9 library plasmid is responsible for suppression of YopT induced
lethality. Each library plasmid clone is unique and only three plasmids were able to
suppress lethality, therefore, the genomic region located within 2T9 is thought to
harbor a Yop target gene. There are three yeast genes located within the 2T9 plasmid:
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Sd-Ura-Leu

Sgal-Ura-Leu

YopT

pRC6 and YopT
pRC6 and YopO

pRC6 and YopE

Figure 1: Suppression of lethality in Yersinia effectors. Yeast strain JGY4 containing
either YopT (pJG495) with a control plasmid (pJG485), YopT (pJG495) with the
suppressor plasmid pRC6, YopE (pJG491) with pRC6 or YopO (pLN5) with pRC6
were replica plated onto SD (SD-ura-leu) or Sgal (Sgal-ura-leu) medium. Cultures
were incubated at room temperature for 3 days. The auxotrophic markers Ura and
Leu were used to select for cells that contained both the expression plasmid as well as
the control or suppression plasmids. The black triangle indicates that each spot of
cells is a 40-fold dilution of the cells in the previous spot.

In order to isolate the specific region of 2T9 needed for suppression, several
subclone constructs were created. Subcloning uses restriction enzyme digestion and

molecular cloning techniques to isolate specific DNA fragments withinthe plasmid.
Then, fractions of the 2T9 plasmid can individually be tested for suppression. Once

the regionwithin 2T9 that is necessary for suppression has been isolated, we can begin
to investigate how this suppression is occurring.

Confirmation of YopT induced lethality was conducted to establish growth

parameters (Figure 2). To achieve this, each plasmid was transformed into yeast via
lithium acetate transformation as previously described (Gietz and Schiestl 1991).

Serial dilution replica plating was performed on Sd-Ura-Leu and Sgal-Ura-Leu media.
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As shown in Figure 2, when two empty vectors were present within yeast cells, wildtype growth was present. When YopT was expressed in cells, growth is inhibited.
When 2T9 was expressed, cellular growth was present as expected. When YopT and
2T9 are both present within the cell, lethality of YopT is suppressed. Lastly, when the

cloning vector was expressed in the presence of YopT, growth was inhibited.
Therefore, cells with empty vectors grow normally, while YopT expression is lethal.
Also, the 2T9 plasmid is capable of suppressing YopT lethality and the library cloning

vector alone was not able to suppress lethality. These results are consistent with data
previously conducted on YopT (Gesier, J.R. unpublished data).
Several subclones of 2T9 were created to examine ability to suppress YopT.

Each of these subclones was transformed into yeast via lithium acetate transformation

as previously described (Gietz and Schiestl 1991). Most of the subclones were

transformed into haploid yeast strain JGY4; however; some of the subclones could not
be transformed into haploid yeast. For subclones pRC2 and pRC3, haploid JGY4

containing the expression plasmid was mated with haploid JGY3 containing the
subclone. This mating produced diploid yeast cells. For pRC4, haploid mating was
not successful so subclones were transformed into diploid yeast strain JGY709. Table

4 summarizes the yeast strain used for the transformation of each subclone.
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Figure 2: YopT suppression controls. Yeast strain JGY4 containing either two
empty vectors (pJG485 and pJG484), YopT (pJG495) and an empty vector (pJG484),
2T9 (pJG551) and an empty vector (pJG485), 2T9 (pJG551) and YopT (pJG495), the
library cloning vector (pGP564) and an empty vector (pJG485) or the library cloning
vector (pGP564) and YopT (pJG495) were replica plated onto SD (SD-ura-leu) or
Sgal (Sgal-ura-leu) medium. Cultures were incubated at room temperature for 3 days.
The auxotrophic markers Ura and Leu were used to select for cells that contained both
the expression plasmid as well as the control or suppression plasmids. The black
triangle indicates that each spot of cells is a 40-fold dilution of the cells in the previous
spot.

Table 4: Haploid and diploid strains used for yeast transformations of 2T9 subclones.

JGY4

Mated JGY4 and JGY3

JGY709

pRC2, pRC3

pRC4

pRCl, pRC5, pRC6, pRC7,

pRC8, pRC9

The growth phenotype of all 2T9 subclones was assessed by serial dilution

replica plating on Sd-Ura-Leu and Sgal-Ura-Leu medium (Figure 3). Cells containing
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each sub clone and either a YopT expression plasmid or an empty vector were
analyzed. The empty vector was used to determine that the subclone plasmid alone

had no effect on cellular growth. The first subclone, pRCl, was created by removing
the SUL1 and VBA2 genes from the 2T9 plasmid. Construct pRC8 was also created
using the same procedures as pRCl and was used to confirm the results seen with
pRCl. As shown in Figure 3A, when pRCl and pRC8 were expressed in conjunction
with YopT, the cells were able to overcome growth inhibition. Therefore, cells were
able to suppress YopT induced lethality. From these results we can conclude that
SUL1 and VBA2 genes are not necessary for suppression. Through the process of

elimination, it was then thought that the PCAI gene was needed for suppression. To
test this, pRC2 was created by isolating the PCAI gene from 2T9 and placing it into a
new cloning vector (pRS426). As shown in Figure 3B, subclone pRC2 was not able

to suppress lethality. In another attempt to remove the PCAI gene, the PCAI gene
was isolated from pRCl and placed into a new cloning vector (pRS426) to create

pRC3. As shown in Figure 3B, pRC3 was unable to suppress lethality. Again, in
another attempt to isolate the PCAI gene, PCAI from pRCl was isolated and placed
into the pGP564 library cloning vector to create pRC4. As shown in Figure 3B, pRC4
was unable to suppress lethality. Therefore, when PCAI is isolated and placed into a
new vector, no suppression occurs. Thus, the PCAI gene is not required for

suppression. To further confirmthese results, pRC6 was created by removing the
PCAI gene from pRCl. As shown in Figure 3A, pRC6 is able to suppress lethality.
These results again suggest that the PCAI gene is not needed for suppression. Also,
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the PCAI gene was isolated from pRC3 and placed back into pRCl in order to create
pRC5. As seen in Figure 3A, pRC5 is able to suppress lethality. Table 5 summarizes
the results of the suppression screen used for these subclones.

Table 5: Summary of suppression of YopT lethalityby various 2T9 subclones.
Suppression
of YopT
Sub-clone

Lethality

pGP564

No

2T9

Yes

pRCl, pRC8
pRC2
pRC3
pRC4
pRC5
pRC6
pRC7
pRC9

Yes

No
No
No
Yes
Yes
Yes
No

An interesting finding was the suppression of the subclone pRC7. In an
attempt to remove the multiple cloning site from the library cloning vector, pGP564
was cut with NotI and the 2.1 kb band was supposed to be removed. However, for

the creation of pRC7, that band was accidentally ligated back into the cloning vector
and therefore, was never removed. As shown in Figure 3A, pRC7 is able to suppress

lethality. Then, pRC9 was made by removing the entire multiple cloning site from the
library cloning vector. As shown in Figure 3B, pRC9 is not able to suppress lethality.
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Figure 3: YopT suppression by 2T9 subclones. Yeast strain JGY4 containing each
sub-clone in the presence of an empty vector (pJG484 or pJG485) or the presence of
YopT (pJG494 or pJG495) were replica plated onto SD (SD-ura-leu) or Sgal (Sgalura-leu) medium. A. The 2T9 subclones that were able to suppress YopT lethality. B.
The 2T9 subclones that were not able to suppress YopT lethality. Cultures were
incubated at room temperature for 3 days. The auxotrophic markers Ura and Leu
were used to select for cells that contained both the expression plasmid as well as the
control or suppression plasmids. The black triangle indicates that each spot of cells is
a 40-fold dilution of the cells in the previous spot.
To assess for a mutation, the OpenBio2 promoter of the cloning vector and

pRC7 were sequenced in the forward and reverse directions by Genewiz, Inc (Figure
4). As seen in Figure 4, sequencing results indicate that both the cloning vector
(pGP564) and pRC7 share complete sequence homology through the multiple cloning
site. Therefore, this mutation might lie on another region of the subclone plasmid that

has not been sequenced. Also, since pRC9 was not able to suppress lethality, these
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results indicate that suppression is not occurring simply through the process of cutting
the cloning vectors with restriction enzymes.

Since all three of the yeast genes located within the 2T9 plasmid have been
removed and suppression still occurs, these genes are not needed for suppression.
This suggests that another piece of the 2T9 plasmid is necessary for suppression. To
investigate the contents of the multiple cloning site within 2T9 and the subclones, the
sequences were evaluated. As shown in Figure 4, along with pGP564 and pRC7, 2T9
and pRC6 share complete sequence homology through the multiple cloning site. The
only exception is the deletion of approximately 50 bp in pRC6. The only other two
noticeable differences occur outside of the multiple cloning site. In the suppressing
constructs, there is a deletion of one adenine base. Also, there is an alteration from a

guanine to an adenine base in 2T9 and pRC6. These results purpose that the multiple
cloning site within 2T9 is not causing suppression.

Lastly, since a few of the subclones could not be transformed into haploid cells,
two suppressor plasmids were transformed into haploid and diploid cells to determine

if ploidy had an effect on suppression. Library plasmid 2T9 and subclone pRCl were
transformed into diploid cells and serial dilution replica plated on SD-Ura-Leu and

Sgal-Ura-Leu media (Figure 5). As shown in Figure 5, both pRCl and 2T9 were able
to suppress lethality in diploid cells as well. Therefore, the ploidy of yeast cells has no
effect on suppression.
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pGP564
pRC7
pRC6
2T9

TTTCTGATGTTCGACTGGTTGCACCA
AGAAATCACAGCCG A (VAGCCATTAAGGTTCTTAAAGCTA1
AGAAATCACAGCCG AAGCCATTAAGGTTCTTAAAGCTATTTCTGATGTTCGACTGGTTGCACCA
AGAAATCACAGCCG AAGCCATTAAGGTTCTTAAAGCTATTTCTGATGTTCGACTGGTTGCACCA
AGAAATCACAGCCG AAGCCATTAAGGTTCTTAAAGCTATTTCTGATGTTCGACTGGTTGCACCA

pGP564GTNGACCGTTTTGaGCTANAAGAATCCCCGTCTGTAATCTTACCATATAGGAACTTTATATATATATATATAACG
pRC7 GTNGACCGTTTTGCTGCTANAAGAATCCCCGTCTGTAATCTTACCATATAGGAACTTTATATATATATATATAA^
pRC6 GTNGACCGTTTTGCTGaANAAGAATCCCCGTaGTAATCTTACCATATAGGAACTTTATATATATATATATAACG
2T9

GTNGACCGTTrTGCrGCTANAAGAATCCCCGTaGTAATCTTACCATATAGGAACTTTATATATATATATATAACG

pGP564AGACTTTACATTTTCCATTCTTTTCAATCTTTCATTCTGaAACGATTGGTGGATAACCTTT^
pRC7 AGACTTTACATTTTCCATTCTTTrCAATCTrTCAnCTGCTAACGATTGGTGGATAACC^
pRC6 AGACTTTACATTTTCCATTCTTTTCAATCTTTCATTCTGCTAACGATTGGTGGATAACaTTTTTGTTATCCAG
2T9

AGACTTTACATTTTCCATTCTTTTCAATCTTTCATTaGCTAACGATTGGTGGATAACCl III IIGTTATCCAGG

pGP564 AATTTATTATAACAGTTGAAGTTCATAACACTACGTTGCTAAATCAGTACTTGCGAAGAGATATACTTTTCGG
pRC7 AA7TTATTATAACAGTTGAAGTTCATAACACTACGTTGCTAAATCAGTACTTGCGAAGAGATATACTTTT
pRC6 AATTTATTATAACAGTTGAAGTTCATAACAaACGTTGCTAAATCAGTACTTGCGAAGAGATATACTTTTCGG
2T9

AATTTATTATAACAGTTGAAGTTCATAACACTACGTTGCTAAATCAGTACTTC^GAAGAGATATACTTTTCGG

pGP564CCAAGGCCGCGAGAGTGGAAAGGAAAAAGAGGGTTAAAAAGTCAACTTTTTCCATATACGCAGTCGaGG
pRC7 CCAAGGCCGCGAGAGTGGAAAGGAAAAAGAGGGnAAAAAGTCAACTTTTTCCATATACGCAGTCGCTGG
pRC6 CCAAGGCCGCGAGAGTGGAAAGGAAAAAGAGGGTTAAAAAGTCAACI111 ICCATATAC GCAGTCGCTGG
2T9

CCAAGGCCGCGAGAGTGGAAAGGAAAAAGAGGGTTAAAAAGTCAAU 1111CCATATAC GCAGTCGCTGG

pGP564AGATCaAGTCACCTACCGTTTATTACTAAAATAAAAaGACTATCACTGGACAAGCAACGTTGTTGTTTAACT
pRC7 AGATCCTAOTCACCTACCGTTTATTACTAAAATAAAACTGACTATCACTGGACAAGCAACGTTGTTGTTTAACT
pRC6 AGATCCTAGTCACCTACCGTTTATTACTAAAATAAAACTGACTATCACTGGACAAGCAACGTTGTTGTTTAACT
2T9

AGATCaAGTCACCTACCGTTTATTACTAAAATAAAACTGACTATCACTGGACAAGCAACGTTGTTGTTTAAa
BssHll

pGPSMATTCGTTACGMGAATATTACGGTTGMATATGTTCrTTTGCACCCAGCCGCGCGGGTGGGAAGCGGGTTATG
pRC7 ATTCGTTACGAAGAATATTACGGnGMATATGnCTTTTGCACCCAGCCGCGCGGGTGGGAAGCGGGTTATG
pRC6 ATTCGTTACGAAGAATATTACGGTTGAAATATGTTCTTTTGCACCCAGCCGCGCGGGTGGGAAGCGGGTTATG
2T9

ATTCGTTACGAAGAATATTACGGTTGAAATATGTTCTTTTGCACCCAGCCGCGCGGGTGGGAAGCGGGTTATG
Pvull

pGP564 CGTTTGGCGGAGGGGGGCGCGCAACCGGCTAAGTAATTACGTCGACCGTGCTGTCCAAAGGGCTGACCTT
pRC7 CGTTTGGCGGAGGGGGGCGCGCAACCGGCTAAGTAATTACGTCGACCGTGCTGTCCAAAGGGCTGACCTT
pRC6 CGTTTGGCGGAGGGGGGCGCGCAACCGGCTAAGTAATTACGTCGACCGTGCTGTCCAAAGGGCTGACCTT
2T9

CGTTTGGCGGAGGGGGGCGCGCAACCGGCTAAGTAATTACGTCGACCGTGCTGTCCAAAGGGCTGACCTT
OpenBio2 Promoter

I

pGP564TCGCCCGTCACTCGCGTTGCGTTAATTACACTCAATCGAGTGAGTAATCCGTGGGGTCCGAAATGTGAAATAC
pPRC7 TCGCCCGTCAaCGCGTTGCGTTAATTACAaCAATCGAGTGAGTAATCCGTGGGGTCCGAAATGTGAAATAC
pRC6 TCGCCCGTCACTCGCGTTGCGTTAATTACACTCAATCGAGTGAGTAATCCGTGGGGTCCGAAATGTGAAATAC
2T9

TCGCCCGTCACTCGCGTTGCGTTAATTACACTCAATCGAGTGAGTAATCCGTGGGGTCCGAAATGTGAAATAC
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Multiple Cloning Site

Cloning SiteForLibrary
Sad

Sacll

Eaql/Notl/Xbal

Spel

I
'
1
pGP564TAACCaCAaAAAGGGAACAAAAGaGGAGCTCCACCGCGGTGGCGGCCGCTaAGAACTAGTGGATCCC
pRC7 TAACCCTCAaAAAGGGAACAAAAGCTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAACTAGTGGATCCC
2T9

TAACCCTCAaAAAGGGAACAAAAGCTGGAGCTCCACCGCGGTGGCGGCCGaCTAGAACTAGTGGATCCC

pRC6

TAACCaCACTAAAGGGAACAAAAGCTGGAGCTCCACCGCGGTGGCGGCC
Pstl/EcoRI/EcoRV

Hindlll

Sall/Xhol

Apal/Kpnl

pGP564CCGGGCTGCAGGAATTCGATATCAAGCTTATCGATACCGTCGACCTCGAGGGGGGGCCCGGTACCCAATTCG
pRC7 CCGGGCTGCAGGAATTCGATATCAAGCTTATCGATACCGTCGACCTCGAGGGGGGGCCCGGTACCCAATTCG
pRC6
AGCTTATCGATACCGTCGACaCGAGGGGGGGCCCGGTACCCAATTCG
Multiple Cloning Site

1

pGP564CCCTATAGTGAGTCGTATTACGCGCGCTCAaGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCG
pRC7 CCCTATAGTGAGTCGTATTACGCGCGaCAaGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCaGGCG
pRC6 CCCTATAGTGAGTCGTATTACGCGCGCTCAaGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCG
Pvull

pGP564TTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTTCGCCAGaGGCGTAATAGCGAAGAGGCCCGCACCGA
pRC7 TTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGTAATAGCGAAGAGGCCCGCACCGA
pRC6 TTACCCAACTTAATCGCCTTGCAGCACATCCCCCrnCCiCCAGCTGGCGTAATAC^GAAGAGGCCCGCACCGA
Pvul

pGP564TCGCCCTTCCCAACAGTTGCGCAGCCTGAATGGCGAATGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCG
pRC7 TCGCCCTTCCCAACAGTTGCGCAGCCTGAATGGCGAATGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCG
pRC6 TCGCCCTTCCCAACAGTTGCGCAGCCTGAATGGCGAATGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCG

pGP564GGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCT/,G<IGCCCGCTCCTTTCGC11 ICI ICC
pRC7 GGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCT/ GIGCCCGCTCCTTTCGCTTTCTTCC
pRC6 GGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCT/ ,A( :GCCCGCTCCTTTCGCTTTCTTCC

pGP564CTTCCTTTarCC^CACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCTTTAGGGTTCCGATT^
pRC7 CTTCCTTTaCC^CACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCTTTAGGGTTCCGATTTA
pRC6 CTrCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCTTTAGGGTTCCGATTTA
Eaql/Sacl/Notl

pGP564GTGCTTTACGGCACCTCGACCCCAAAAAACTTGATTAGGGTGAAGGGGGCGGCCGCGGAGCaGCTTTTTT
pRC7 GTGCTnACGGCACaCGACCCCMAAAACTTGAnAGGGTGMGGGGGCGGCCGCGGAGCCTGCTTTTTT
pRC6 GTGCTTTACGGCACaCGACCCCAAAAAACTTGATTAGGGTGA

Figure 4: YopT suppressor sequences. The cloning vector (pGP564), 2T9, pRC7 and
pRC6 were all sequenced in the forward and reverse directions of the OpenBio2
promoter. The OpenBio2 promoter and the library cloning site are indicated by black
arrows while white arrows denote the ends of the multiple cloning site. The brackets

designate specific restriction enzyme sites and dashes represent bases that are not
present. The two areas of variation between sequences are outlined with a rectangle.
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Figure 5: Effects ofploidy on suppression. Yeast strains JGY709 (diploid) and JGY4
(haploid) containing either 2T9 (pJG551) and YopT (pJG495) or pRC6 and YopT
(pJG495) were replica plated onto SD (SD-ura-leu) or Sgal (Sgal-ura-leu) medium.
Cultures were incubated at room temperature for 3 days. The auxotrophic markers
Ura and Leu were used to select for cells that contained both the expression plasmid as
well as the control or suppression plasmids. The black triangle indicates that each spot
of cells is a 40-fold dilution of the cells in the previous spot.
YopT Effector Protein Expression

The previously stated results demonstrate that some of the 2T9 subclone creations

were able to suppress YopT induced lethality, while others could not. The suppressor
subclones may be deactivating YopT by derealization, or degradation of the protein.
It is also possible that the suppressor is able to repress the GALl promoter, thus
preventing expression of YopT. We investigated how the suppressors were able to

overcome YopT induced lethality using Western immunoblotting as previously
described (Sambrook et al. 1989). Western immunoblotting is an assay that detects
relative size and concentration of proteins through the use of antibody staining. Since

the YopT expression plasmids contain a V5 epitope, the anti-V5 antibody and a
horseradish peroxidase reagent fluorescent tag were used to detect the YopT protein.

First, normal YopT expression levels within yeast cells were examined (Figure 6).
To detect YopT, yeast cells containing a YopT expression plasmid and an empty
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vector were grown to mid-log phase in minimal selective media. Protein expression
was induced with galactose and extracts were prepared from each aliquot as

previously described (Kahana et al. 1998). As shown in Figure 6, YopT migrates in
the gel at approximately 35 kDa. This is consistent with data previously published
(Iriarte and Cornells 2002).

Next, it was important to investigate if the suppressing subclones had an effect on
YopT expression (Figure 7). It was hypothesized that the possible mechanism for

suppression was the degradation of YopT by the subclones. As shown in Figure 6,
when a suppressor is present within the cell, there are no detectible levels of YopT.
For consistency, YopT protein expression in all of the subclones was observed. As
seen in Figure 7, YopT in all non-suppression subclones (pGP564, pRC2, pRC3,

pRC4, pRC9) migrates to approximately 35kDa within the gel. Conversely, no YopT
is detected in the suppressor subclones: 2T9, pRCl and pRC5. This is consistent with
the theory that YopT is being degraded by the suppressor, but it was also possible that

YopT was not being produced withinthe cells. Therefore, further investigation was
needed to determine exactly how YopT was deactivated. Another interesting finding

is that pRC7 was able to suppress lethality, but YopT is detected withinthe gel at
35kDa when pRC7 was present.
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Figure 6: YopT expression in yeast cells. Yeast strain JGY4 containing YopT
(pJG495) in conjunctionwith an empty vector (pGJ484) or suppressor (pRC6) were
grown in S raffinose-Ura-Leu media. Cultures were induced with 2% galactose for 4
hours. Aliquots were taken at respective time points and protein extracts were
prepared as previously described by Nejedliket al. 2004. The same concentration of
YopT proteinwas added to each well and YopT was detected with a V5 epitopeby
immunoblotting. Molecular weight marker is shown. Arrow indicates the expected
molecular weight of YopT protein.
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Figure 7: YopT expression in subclone constructs. Yeast strain JGY4 containing
YopT (pJG495 and pJG494) in conjunctionwith either 2T9 (pJG551), the library
cloning vector (pGP564), pRCl, pRC2, pRC3, pRC4, pRC5, pRC7 or pRC9.
Cultures were induced with 2% galactose for 3 hours. Aliquots were taken at hour 3
and protein extracts were prepared as previously described by Nejedliket al. 2004.
The same concentration of YopT protein was added to each well and YopT was
detected with a V5 epitope by immunoblotting. Molecular weight marker is shown.
Arrow indicates the expected molecular weight of YopT protein.
Localization of YopT Effector

To further investigate the mechanism of YopT lethality suppression, the
cellular localization of YopT was examined (Figures 8 and 9). It is currently unknown

what compartment of the cell YopT localizes to within yeast cells. It maybe found in
the periphery, in certainorganelles, or diffused all over the cytoplasm. A clear picture
of where it is located can give insight into how it functions within the cell. Cellular
localization was examined by immunofluorescence as previously described (Nejedlik et
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al. 2004). Indirect Immunofluorescence allows for visualization of the effector protein

within the cell through the use of antibody staining. Similar to western blotting, antiV5 antibody was used in conjunction with a fluorescent tag. Yeast cells containing a
YopT expression vector along with an empty vector were induced with galactose and

samples were collected at various time points. The samples were then prepared for
indirect immunofluorescence as previously described (Nejedlik et al. 2004). As shown
in Figures 8 and 9, YopT can be found diffused and localized all over the cell.
Numerical counts of cells expressing YopT were performed at hours 3 and 4. As
shown in Table 6, at hour 3, 87% of cells contained detectible levels of YopT and at

hour 4, 81% contained YopT. Therefore YopT is abundantly localized all over the

cell when expressed in yeast. Also, shown in Figure 9, DNA is localized the nucleus
of cells and mitochondrial DNA can found on the periphery of cells.

Table 6: Cellular counts of YopT effector expression.

Time

% of cells containing

% of cells not containing

Point

YopT

YopT

YopT with Empty
Hour 3

87

13

Hour 4

81

19

YopT and

Hour 3

7

93

pRC6

Hour 4

6

94

Vector

The cellular localization of YopT was also examined in the presence of a

suppressor to determine if there was a detectible change in localization. Yeast cells
containing a YopT expression plasmid and a suppressor plasmid (pRC6) were induced
with galactose and samples were collected at various time points. The samples were
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then prepared for indirect immunofluorescence as previously described (Nejedlik et al.
2004). As shown in Figures 8 and 9, very low amounts of YopT were present at all

time points. To confirm these results, numerical counts of cells expressing YopT were
conducted at hours 3 and 4. As shown in Table 6, only 7% of cells at hour 3 and 8 %

at hour 4 had visible YopT expression.

Therefore, when a suppressor plasmid is

present, YopT expression is significantly reduced. These data is consistent with the
protein expression levels seen in the previous Western blots. Since detectable levels of

YopT are still present in a few cells, it is unlikely that the suppressor is preventing
YopT expression by repressing the GALl promoter.

Also, we can conclude that

suppression is not due to a malfunction of the cloning vector or subclone constructs.
Lastly, immunofluorescence was conducted on diploid and haploid cells to

determine if ploidy had an effect on YopT localization (Figure 10). As shown in
Figure 10, in both haploid and diploid cells, YopT is found diffused all over the cell.
These results indicate that there is no difference in YopT expression in haploid versus

diploid cells. Therefore, the ploidy of yeast cells has no effect on the localization of
YopT within yeast cells.
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Un-induced

Induced

YopT

YopT with pRC6

Figure 8: Localization of YopT. Yeast strain JGY4 containing YopT (pJG495) and
either a control plasmid (pJG484) or a suppressor plasmid (pRC6) was grown in
selective media containing 2% raffinose. YopT was induced with 2% galactose after
time point zero. Aliquots were taken at each time point and fixed with 3.7%
formaldehyde for 18 hours at 4°C. Immunofluorescence was used to visualize the V5
epitope as previously described by Nejedlik et al. 2004.
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Figure 9: Individual cell view of localization of YopT. Yeast strain JGY4 containing
YopT (pJG495) along with either an empty vector (pJG484) or a suppressor plasmid
(pRC6) were grown in selective media containing 2% raffinose. YopT was induced
with 2% galactose after time point zero. Aliquots were taken at each time point and
fixed with 3.7% formaldehyde for 18 hours at 4°C. Immunofluorescence was used to
visualize the V5 epitope and DAPI was used to visualize DNA as previously described
by Nejedlik^ al. 2004.
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Figure 10: Effects ofploidy on YopT localization. Yeast strains JGY4 and JGY709
containing YopT (pJG495) and control plasmid (pJG484) were grown in selective
media containing 2% raffinose. YopT was induced with 2% galactose after time point
zero. Aliquots were taken at each time point and fixed with 3.7% formaldehyde for 18
hours at 4°C. Immunofluorescence was used to visualize the V5 epitope and DAPI
was used to visualize DNA as previously described by Nejedlik et al. 2004.
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Chapter III: Discussion
Through the use of a yeast model system, the cellulartargets of the Yersinia

outer proteins, or Yops, were investigated by the use a dosage-dependent suppression
selection. From this selection, 2T9 was identified as a plasmid that could suppress
YopT lethality. There are three yeast genes located within 2T9; SUL1, VBA2 and

PCAI. Our preliminary hypothesis was that a single gene, multiple genes, or part of a
gene, were necessary for suppression of YopT lethality. However, upon creation of
several 2T9 subclones, it was discovered that when all three yeast genes were
removed, suppression still occurred. Therefore, suppression was not caused by one of

the yeast genes. We then analyzed sequencing data to determine if there was an aspect
within the multiple cloning site, other than the yeast genes, that may be causing
suppression. As presented in the sequencing data, there is no difference in the DNA

sequence within the multiple cloning site, between the library cloning vector and the

suppressing constructs. Therefore, the unique genomic insert within the 2T9 plasmid
is not responsible for suppression.

After the creation of pRC9, we made many attempts to remove various
fragments from the 2T9 plasmid and several of the subclone constructs.
Unfortunately, we were unable to cut DNA from the multiple cloning site near the
OpenBiol promoter. The restriction enzymes were not functioning within this region
despite the sequencing data proving that these sites existed. Hence, we were unable to

narrow down the region within the 2T9 plasmid needed for suppression. It is possible
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that this region may be found outside of the multiple cloning site, however, it is more
likely that suppression is occurring by means not currently apparent to us.

The conclusion that suppression is not caused by the genomic DNA within the

2T9 plasmid is reinforced by the data collected on subclone pRC7. It was noted that
pRC7 was able to suppress lethality though we could not detect a difference in the
DNA sequence between this subclone and the library cloning vector it was made from.
Thus, a non-suppressing construct became a suppressing construct with no known
cause. Another interesting finding was the results from the Western blot assay
conducted on YopT in the presence of pRC7. When YopT was expressed in the

presence of all other suppressor subclones, expression levels were decreased.
However, YopT was still present in cells that contained the pRC7 suppressor.

Therefore, it is possible that pRC7 was not suppressing YopT through the same
mechanism as the other suppressor constructs.

When YopT was visualized within yeast cells, it diffused all over the cell. It
was not localized to any one compartment within the cell. Also, when YopT was

visualized in the presence of a suppressor plasmid, protein expression was greatly
reduced. Therefore, YopT was still produced, but it was possibly degraded by the
suppressor.

Lastly, our results proved that suppressionby 2T9 was not specific to YopT.
Rather, 2T9 could suppress YopO and YopE induced lethality as well. This indicates
that the suppressor effects are not unique to YopT. These results suggest that the
mechanism for suppression is not occurring through the involvement of the specific
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interactions of YopT within in the cell, such as the untethering of Rho A, Racl and
CDC42. Rather, suppression may be occurring through the interaction with an
intermediate that all three Yops interact with within the Rho GTPase cycle.

From the information gathered through this research, we were unable to

determine why the unique 2T9 plasmid was able to suppress YopT induced lethality.
Hence, we were unable to assess the possible mechanisms of lethality suppression.
From this, we have concluded that our dosage-dependent suppression selection in

yeast may identify false positives that need to be controlled for. In the future, it is
important to isolate the region of the 2T9 plasmid needed for suppression. To do this,
the entire 2T9 plasmid, along with the pGP564 cloning vector, need to be sequenced
to assess for differences. Any difference in the sequence data may indicate a possible
region necessary for suppression.

Another future direction for this research is to investigate how suppression of

YopT lethality is occurring. Suppression may be occurring through the destabilization
of the YopT expression plasmid or degradation of the YopT protein. Another

possibility is the prevention of YopT protein expression through repression of the

GALl promoter. However, since 6-7% percent of cells in cultures containing both
YopT and the suppressor plasmid show YopT staining, it is unlikely that YopT is not
being expressedwithinthe cells. Also, through plasmid selection using auxotrophic
markers, it is unlikely that the yeast cultures are not maintaining the YopT expression

plasmid. Finally, there may be an additional factor causing suppression that is not

currently apparent to us. Further research to isolate the regionwithin 2T9 needed for
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suppression, and examination of how that region is causing suppression, can give good

insight into what YopT targets within yeast cells to cause lethality.
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